Efficacy and Safety of Combination Therapy Consisting of Angiotensin II Type 1 Receptor Blocker, Calcium Channel Blocker and Hydrochlorothiazide in Patients With Hypertension

BACKGROUND: Many patients continue to have high blood pressure (BP) even after treatment with high-dose (H)-angiotensin II type 1 receptor blocker (ARB)/calcium channel blocker (CCB) or middle-dose (M)-ARB/CCB/hydrochlorothiazide (HCTZ). METHODS: Thirty-two hypertensive patients who had the use of H...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Clin Med Res
Päätekijät: Shiga, Yuhei, Miura, Shin-ichiro, Motozato, Kota, Yoshimine, Yuka, Norimatsu, Kenji, Arimura, Tadaaki, Koyoshi, Rie, Morii, Joji, Kuwano, Takashi, Inoue, Ken, Shirotani, Tetsuro, Fujisawa, Kazuaki, Matsunaga, Eiyu, Saku, Keijiro
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elmer Press 2017
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5215013/
https://ncbi.nlm.nih.gov/pubmed/28090225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2838w
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia